News Detail

Research into a novel form of cell death is entering its next phase and could soon help reduce complications after heart attacks or organ transplants. The Federal Ministry of Research, Technology, and Space (BMFTR) is providing continued support for…

Futuristic medical concept with red human lungs

The European Respiratory Society (ERS) and COPD-iNET Research Symposium in Prague brought together more than 120 clinicians, researchers, and patient advocates to address one of the most pressing challenges in respiratory medicine: Chronic…

World COPD Day aims to raise awareness, share knowledge, and promote action to reduce the global burden of chronic obstructive pulmonary disease (COPD). Helmholtz Munich is driving progress in these efforts, with pioneering research on new…

When nanoparticles enter the lungs, the immune system reacts within minutes. Researchers from the Institute of Lung Health and Immunity (LHI) at Helmholtz Munich have now revealed how alveolar macrophages – immune cells located in the lung’s air sacs…

Helmholtz Munich has secured funding in the Helmholtz Association’s first-ever “UNLOCK” call for AI benchmarking. The LHI is proud to include its AI and lung research expertise in two approved projects:

In recent biomedical research, the phrase lung-deposited dose is coming more frequently into focus - and for good reason. A new comment by LHI's Lin Yang and Otmar Schmid urges scientists, bioengineers, and drug developers to pay much closer…

All News

Funding for Cell Death Research Extended

ERS–COPD-iNET: International Research Symposium Highlights Opportunities for Early Intervention in COPD

World COPD Day 2025

How Lung Cells Initiate the Immune Response to Nanoparticles

Institute of Lung Health and Immunity and Helmholtz Munich to Advance AI Benchmarking With Two Newly Funded Projects

Why measuring lung-deposited dose matters - and what it means for future treatments of lung diseases